To monitor intracranial tumor growth, Luc-expressing CD133+ cells (5 × 103 cells) derived from U87 glioma cells were injected intracranially into athymic mice, and tumor growth was assessed using the IVIS-200 imaging system. This evidence concerns the gene PROM1 and central nervous system cancer.